Womens Healthcare Journal Media

Media

Curio Publishes Results of MamaLift Plus Human Factors Trial

Curio has shown that its prescription digital therapeutic product for postpartum depression is acceptable, feasible, and usable.

Read More

Curio to Participate in Upcoming HPIR Roundtable

Of approximately 20 nominations, Curio was selected as one of 10 teams to join the Academy Class of Fall 2022.

Read More

Cooking & Conversation Features Curio Digital Therapeutics

Read More

Managing the holidays with a newborn

Managing the holidays with a newborn can be challenging. Check out our tips to help make it a bit easier.

Read More

Curio Highlight Snippets

Check out some snippets from our various media appearances!

Read More

Three Tips On Why Physical Health is Important for Mental Health

Check out this helpful blog post by our in-house clinical psychologist Dr. Anju Bhargava and her partner Maahi Jain.

Read More

Curio Selected as one of Business Insider’s 34 of the Most Promising Women’s Health Startups of 2022

We are proud to announce that we have been selected as one of Business Insider’s 34 of the most promising women’s health startups of 2022, according to VCs!

Read More

Curio Featured on the Balancing Act on Lifetime TV

Read More

Curio Digital Therapeutics Partners with Axia Women’s Health To Support Patients with Postpartum Depression

Check out this fantastic article about why Axia chose to partner with us!

Read More

Curio Announces new Scientific Advisory Board Members

Read More

Under the Microscope: Curio

Why Avestria Invested in this Digital Therapeutics Startup

Read More

Curio welcomes Dr. Anju Bhargava

Read More

FONSECA, A., GORAYEB, R., & CANAVARRO, M. C. (2016).

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS

Women’s use of online resources and acceptance of e-mental health tools during the perinatal period

Read More

FONSECA, A., PEREIRA, M., ARAÚJOPEDROSA, A., MOURA-RAMOS, M., GORAYEB, R., & CANAVARRO, M. C. (2018)

COGNITIVE AND BEHAVIORAL PRACTICE

Be a Mom: Formative evaluation of a webbased psychological intervention to prevent postpartum depression

Read More

A., MONTEIRO, F., ALVES, S., GORAYEB, R., & CANAVARRO, M. C. (2019)

FRONTIERS IN PSYCHOLOGY

Be a Mom, a web-based intervention to prevent postpartum depression: The enhancement of self-regulatory skills and its association with postpartum depressive symptoms

Read More

FONSECA, A., ALVES, S., MONTEIRO, F., GORAYEB, R., & CANAVARRO, M. C. (2020)

BEHAVIOR THERAPY

Be a Mom, a web-based intervention to prevent postpartum depression: Results from a pilot randomized controlled trial

Read More

MONTEIRO, F., PEREIRA, M., CANAVARRO, M. C., & FONSECA, A. (2020)

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH

Be a mom’s efficacy in enhancing positive mental health among postpartum women presenting low risk for postpartum depression : Results form a pilot randomized trial.

Read More

Shailja Dixit

Shailja Dixit

Chief Executive Officer

Dr. Dixit is a Physician Executive with more than 20 years of experience in the healthcare and life sciences industry. She has been in executive leadership at Sanofi, Allergan, and GE and has been responsible for launching a number of innovative medicines. She was voted innovator of the year at GE in 2008, nominated as a Top 50 Thought Leader in “Big Data” in Life Sciences in 2016, and featured in the Pharma Executive Magazine cover-page article “Real-World Evidence: From Volume to Value” (Oct 13, 2016). Shailja has built and has had successful exits with many projects.

Erin Russell

Erin Russell

VP of Product and Marketing

Healthcare executive with extensive experience in Product, Marketing, and Commercial. Founder of Health Grizzly, a digital health platform helping seniors access care. Founder and General Manager of Spotlyte, a digital health venture focused on facilitating the consumer journey into treatment through education and engagement. In addition to her entrepreneurial experience, Erin has 20+ years commercial experience at pharmaceutical companies, including Merck, Schering-Plough, and Allergan. She has built and led commercial teams and business units, launched products, and reinvigorated sales of in-line products. Erin holds a B.S. in Chemistry from University of Arizona and an M.B.A. from Harvard Business School.

Amrik Shah

Amrik Shah

Chief Analytics Officer

Amrik brings 20+ years of experience in the strategic design and analysis of clinical trials and management/co-ordination with specialized CROs in areas of Statistics and Programming, including machine learning/AI. His experience in drug development spans Discovery thru Phase 3 clinical trials with time spent at various big and small Pharma companies. His recent experiences include consultation for various biotechs in the areas of liver disease, cell therapy and rare diseases such as ALS and PSC.

Amrik is passionate in leveraging the intersection of statistics, logic and analytics as applied to real world data to develop robust and refined algorithmic tools for identifying, managing and treating patients. Beyond that, his areas of interest include sequential designs, hypothesis testing with multiplicity control, longitudinal/mixed models including PK/PD and small sample inference. He holds a B.E. from Punjab Engineering College, India and a doctorate (ScD) in Biostatistics from Harvard University.

Anju Bhargava

Anju Bhargava

Director of Products and Content

Dr. Anju Bhargava earned her Ph.D. in Counseling Psychology from Washington State University, an American Psychological Association (APA) accredited program. She completed an APA-accredited predoctoral internship at the University of Delaware Counseling Center. She is a licensed psychologist in the state of Washington since 2014 and is a member of the APA. Prior to Curio Digital Therapeutics, she worked as a Research Psychologist for the Department of Defense, Defense Health Agency, Connected Health Branch formerly known as the National Center for Telehealth and Technology. She is passionate about combining psychology and technology as she previously co-founded iMomConnect, a child development company focused on promoting optimal cognitive, social, emotional, and physical development in children using mobile applications. In addition, she has previously served as an Assistant Professor of Psychology for undergraduate and graduate students.

Indira Malladi

Indira Malladi

Manager of Research and Development

Indira is a graduate of Rutgers, The State University of New Jersey with a double major in Public Health (B.S.) and Economics (B.A.). Her drive as a public health advocate is fueled by a desire to rise beyond professional silos and cultivate interdisciplinary partnerships. She believes equitable community partnerships are a cornerstone of eliminating health disparities. She manages clinical trials for Stella.

Bobby Keough

Product Design & Marketing Manager

Bobby is a graduate of Hofstra University and a multi-media digital artist. From creating graphics to designing user experience, he helps to shape the creative direction of Curio’s products and marketing. Bobby believes in combining science and art through technology to empower a better tomorrow.

Mayuresh Dalal

Mayuresh Dalal

Director of Technology Implementation

A proven team leader and manager known for successfully assisting the launch of high-quality software releases on schedule and on budget through the utilization of agile methodologies. Enabling technology solutions to be informed by the needs of the business by being a true partner to all parts of the organization. Mayuresh leads Curio’s digital products engineering team, which is responsible for developing the company’s direct-to-consumer and enterprise technology platforms. He is responsible for defining the long-term technology strategy and vision for Curio’s innovative digital products. Mayuresh holds a MS degree in Computer Science & Information Systems from Pace University, New York, as well as a Software Engineering degree from Mumbai University, India.

Fabiana Monteiro

Fabiana Monteiro

Clinical Content and Research Specialist

Fabiana is a mental health researcher and clinical psychologist who is passionate about evidence-based digital health solutions and the role of technology in the future of healthcare. She is particularly interested in an approach that promotes positive mental health at a population level rather than a sole focus on treating and preventing disorder. Her work has focused on targeting the development and strengthening of psychological resources, such as acceptance-, mindfulness- and compassion-based skills. Her PhD project focused on a randomized controlled trial of a web-based intervention to promote maternal mental health. She has also conducted research on psychotherapeutic processes such as acceptance, mindfulness, and self-compassion. Fabiana has been involved in different research projects in the Center for Research in Neuropsychology and Cognitive Behavioral Intervention (University of Coimbra), including the development of a mobile-based intervention for perinatal mental health during the COVID-19 pandemic and in designing the clinical trial of a mindfulness web-based intervention for promoting mindful parenting. She is experienced in planning and executing research projects and in the dissemination of results. She has authored and co-authored over 10 articles in peer-reviewed journals and presented several works in scientific events. A big passion for travel, food, and music helps her remain sane and fuels my working hours.

Shailja Dixit

Shailja Dixit

Chief Executive Officer

Dr. Dixit is a Physician Executive with more than 20 years of experience in the healthcare and life sciences industry. She has been in executive leadership at Sanofi, Allergan, and GE and has been responsible for launching a number of innovative medicines. She was voted innovator of the year at GE in 2008, nominated as a Top 50 Thought Leader in “Big Data” in Life Sciences in 2016, and featured in the Pharma Executive Magazine cover-page article “Real-World Evidence: From Volume to Value” (Oct 13, 2016). Shailja has built and has had successful exits with many projects.

Sidhartha Shankar

Sidhartha Shankar

Director

Sidhartha has more than 20 years of Technology Management experience. Most recently, he was CTO of Ediom, LLC, an AI/ Big Data startup focused on building data products for the provider market in a JV with Vizient, the largest GPO in USA. Prior to that, he was Managing Partner of iMedInvestments LLP, a cross-border advisory investment banking firm, and also VP of IT for Walkingspree Inc.- a specialty wellness provider. Sidhartha is a graduate of the Wharton Business School and the University of Pennsylvania and also a Software Engineering degree from NIT, India.

Anne Whitaker

Anne Whitaker

Director

Anne is a seasoned healthcare executive with more than 28 years of experience across multiple companies and geographies. She has a proven track record of building and leading high-performance teams to successfully commercialize pharmaceuticals, consumer products and medical devices. Anne has been recognized in the pharmaceutical industry by Fierce Pharma as one of the top 25 Most Influential People in BioPharma in 2012 and 2013, and in 2014 as one of the top 25 Most Influential Women in BioPharma. She was recently recognized by PharmaVoice as one of the Top 100 most Inspiring Leaders in Healthcare and by Women, Inc. as one of the most Influential Corporate Directors in 2019. She is a member of Women Corporate Directors, Healthcare Businesswomen’s Association, International Women’s Forum and OnBoardNC. Anne is the current Chairman of Aerami Therapeutics, She serves as an independent director on the board of Cree, Mallinckrodt, and UDG Healthcare. She also serves on the Board of Trustees for the Univ. of North Alabama, her alma mater. She is an active industry advisor to private equity and venture capital funds in the US and Europe. Anne served as the President of the North America Region Head where she led team to deliver ~$10B in net sales equaling > 30% of the net sales. Anne served as the CEO and President of Synta Pharmaceuticals, in 2014 and 2015. She joined Bausch Health as an Ex. VP and Company Group Chairman for the Branded Pharmaceuticals segment in mid-2015. Later she served as the CEO and President of Novoclem Therapeutics, Inc. Anne holds a Bachelor of Science degree in chemistry from the University of North Alabama.

Jean-Pierre Lehner

Jean-Pierre Lehner

Director

Jean-Pierre LEHNER MD, cardiologist and internal medicine graduate served the pharmaceutical industry for 30 years. Before joining pharmaceutical industry Jean-Pierre was practitioner in Hospital Bichat, Paris (France), where during the last 4 years he was heading the Intensive Care Unit of Cardiology.

Dr. Lehner assumed various roles in medical affairs. In 1981, he joined Roussel-Uclaf Company first as medical director in France, then in charge of international clinical development untill1992. Dr. Lehner served successively at Sanofi as Head of Clinical Development for 4 years before taking the scientific director position in France until 2002 and developed the European medical team before taking the position of Global Medical Director in 2005.

In 2009 Dr. Lehner was appointed as Senior Vice President & Chief Medical Officer reporting to the Head of R&D and to Sanofi’s CEO. In this position Jean-Pierre had responsibility for world-wide medical affairs, regulatory affairs, safety and HEOR research including comparative effectiveness. During these years Jean-Pierre had acquired à very large expertise in the benefit-risk assessment of marketed and non-marketed products and defended many regulatory files in front of the Global agencies.

Well-respected in the medical community & pharmaceutical industry, Dr. Lehner led the development of new concepts within Medical affairs to fit the external evolution such as Innovative methodologies for Real world research and development of Relative Medical Value to enhance the patient – centric value of drug development and played key role in enhancement of coverage and reimbursement dossier development.

He is now Executive Director of his own company (JPLPHARMA CONSULTING).

Catherine Monk

Catherine Monk

Scientific Advisor

Catherine Monk, PhD, is a Professor in the Departments of Obstetrics & Gynecology and Psychiatry at Columbia University Irving Medical Center and Research Scientist VI at the New York State Psychiatric Institute. Dr. Monk oversees the integrated women’s mental health program in Obstetrics & Gynecology. Dr. Monk’s research brings together the fields of psychopathology, developmental psychobiology, developmental neuroscience, and perinatal psychiatry to focus on the earliest influences on children’s developmental trajectories—those that happen in utero—and how to intervene early to prevent mental health problems

Jian Jenny Tang

Jian Jenny Tang

Scientific Advisor

Dr. Jian Jenny Tang has over 20 years of experience in general obstetrics and gynecology. Dr. Tang is an advocate for her patients by balancing modern western medicine and holistic eastern medicine. Dr. Tang also has a strong interested in reproductive health and women’s wellness. Lastly, she is involved in the North America Asian American fitness community, providing health and exercise guidelines to women before, during and after pregnancy.

Komal Dutt, PhD

Komal Dutt, PhD

Scientific Advisor

Dr. Komal Dutt received her Ph.D. from State University of New York at Albany. She has completed an American Psychological Association approved internship at University of Pittsburgh Counseling Center and has completed her post-doctoral training at Drew University Counseling Center. She has also worked at a community mental health center in upstate N.Y. She received a Masters in Organizational Behavior from University of Delhi, India. She is skilled in treatment of depression, anxiety, stress, relationship issues, self-esteem, body-image, women’s, and career related issues.

Ana Fonseca, PhD

Ana Fonseca, PhD

Clinical Content Expert And Research

Dr. Fonseca is post doctoral fellow at university if Coimbra, Portugal. She has conducted multiple years of research and published several studies in area of post-partum depression. Her research led to development of beamom program. Be a Mom is a selfguided, web-based intervention to prevent persistent postpartum depression symptoms [PPD], targeting both at-risk postpartum women and/or women presenting early-onset postpartum depressive symptoms. Be a Mom is grounded on the principles of Cognitive-Behavior Therapy. Curio^TM has exclusive right to beamom content and principles have been incorporated in Stella program.

Maria Cristina Canavarro

Maria Cristina Canavarro

Scientific Advisor

Maria Cristina Canavarro is Full Professor at the Faculty of Psychology and Educational Sciences of the University of Coimbra (FPCE-UC); researcher, and coordinator of the Center for Research in Neuropsychology and Cognitive and Behavioral Intervention and the Research Group Relationships, Development & Health of CINEICC. She is also Director of the Cognitive Behavioral Unit of the University of Coimbra and member of the National Ethical Committee for Clinical Research (CEIC). She is member of the Order of Portuguese Psychologists (OPP), recognized as expert psychologist in Clinical and Health Psychology, with advanced expertise in Psychotherapy and Early Intervention. She was, for twenty-one years, responsible for the Unit of Psychological Intervention (UnIP) of the Daniel de Matos Maternity, Integrated Management Area in Maternal-Fetal Health, of the Coimbra Hospital and University Center (CHUC, EPE). Maria Cristina Canavarro has participated, as principal researcher, member, and consultant, in different R&D research projects and other scientific projects. She is the co-Principal Investigator of the project “BeAMom Trial, a web-based psychological intervention to promote maternal mental health” (CENTRO-01-0145-FEDER-028699). She has published more than 240 articles in international peer review scientific journals and more than 90 articles in national peer review scientific journals as well as several book chapters and books.

Robert Honigberg, MD, MBA

Robert Honigberg, MD, MBA

Advisor

Robert Honigberg, MD, MBA. Robert is a former surgeon and an experienced clinical leader in a variety of therapeutic areas who taught strategy as a former Adjunct Professor of Health Enterprise Management at Kellogg Business School/ Northwestern University. He is the former Chief Medical Officer of GE Healthcare. He has also held positions of medical leadership in clinical development, business development, and medical affairs at Schering-Plough Oncology, Ortho Biotech, CardioDx, Flexion Therapeutics, Baxalta and Shire. He has designed and executed a myriad of clinical studies and is a current member of the MAPS Evidence Generation Focus Area working group Dr. Honigberg is a graduate from Duke University with a BA in Economics, obtained his medical degree and later MBA from Kellogg School of Management.

Mark Devlin

Mark Devlin

Advisor

Mark is a Curio^TM Director and Executive with more than 30 years of experience in the biopharmaceutical industry. He is a former SVP of Market Access at Allergan, held similar positions at Actavis and Forest Laboratories, and has a deep understanding of the US payer system. He has also consulted for more than a dozen pharma clients, helping with commercial strategy, Hub and patient services, pricing strategy, and business development. Mark has a BS in Biology and Chemistry from Fairleigh Dickinson University and studied at the FW Olin School of Business at Babson College.

Haita Makanji

Haita Makanji

Advisor

Dr. Haita Makanji joined Magellan Rx Management in 2014. She is currently the vice president of clinical strategy and innovation within specialty in which she assumes several roles and responsibilities, including development and management of specialty clinical programs and interfacing with payers and pharmaceutical companies to bring unique solutions to curb the rising specialty spend. For clinical program development and management, she is responsible for design, implementation, and day-to-day operations of specialty programs that improve the quality of care for patients with high cost disease states including but not limited to rheumatoid arthritis, multiple sclerosis, oncology, and rare diseases such as hemophilia. Furthermore, she oversees the MRx Comprehensive Oncology Management Program which encompasses utilization management with unique strategies to curb the rising spend in oncology and complex case management. A significant portion of her role has also expanded to lead clinical program development efforts for other lines of business including employer groups and Medicaid plans. Additionally, Dr. Makanji leads a team of pharmacists, including board-certified oncology pharmacists who are tasked to support payers and assist with comprehensive medical and pharmacy data analyses, prior authorization and medical policy design, and organizing unique key opinion leader thought leadership panels. Dr. Makanji has been in the healthcare industry for over 10 years. She began her career as a HIV-certified pharmacist at Walgreens and transitioned to managed care in early 2012 with CDMI, LLC (which was later acquired by Magellan Rx Management in 2014). Dr. Makanji earned a Doctor of Pharmacy from Massachusetts College of Pharmacy and Health Sciences in Boston, MA. She is currently a registered pharmacist in both Rhode Island and Connecticut and has additional advanced training in HIV from University of Buffalo, and medication therapy management and immunizations from the American Pharmacists Association (APhA). Dr. Makanji also serves as president of the Northeast affiliate of the Academy of Managed Care Pharmacy (AMCP).

Gallagher

Axia

Mount Sinai

Mount Sinai

Columbia University

Columbia University

University of Coimbra

BeAMom

X